|
Week - 1
|
Introduction and definitions |
|
Week - 2
|
Bioavailability differences among oral dosage forms |
|
Week - 3
|
Pharmacokinetic parameters defining bioavailability |
|
Week - 4
|
Importance of disintegration time |
|
Week - 5
|
Effect of production variables of solid forms on bioavailability |
|
Week - 6
|
Bioavaliability of oral solutions |
|
Week - 7
|
Bioavailability of suspensions |
|
Week - 8
|
Bioavalability of immediate release tablets |
|
Week - 9
|
Bioavailability of long-acting tablets |
|
Week - 10
|
Bioavailability of inhalation products |
|
Week - 11
|
Bioavailability of capsules |
|
Week - 12
|
Bioavalability of emulsions |
|
Week - 13
|
Bioavailability of new drug delivery nanoparticular systems |
|
Week - 14
|
Discussion and evaluation |
Anadolu Info Package 
Turkish
English